Covidien plc subsidiary Ev3 Inc. issues a recall for its NanoCross .014" OTW PTA peripheral artery dilatation catheter; Food & Drug Administration classifies recall as serious.

Ev3 Inc. initiated a recall for certain lots of its NanoCross .014" OTW PTA dilatation catheter.
The Plymouth, Minn.-based Covidien plc (NYSE:COV) subsidiary is taking the peripheral artery surgical instruments off the shelves because of a potential for the catheter's shaft to crack or break during procedures using balloons to dilate blood vessels.
Medical monitoring devices maker IntriCon says it's going to lay off 35 of its employees as part of a...
The FDA grants conditional approval for another arm of HeartWare International's clinical trial of...
Georgia medical device maker Theragenics gives private equity firm Juniper Investment Co. an extra...
56% of surveyed manufactures were unprepared for HC reform, and most cited rising costs as a top...